ARCHIVES

Drug Discover Groups Recompetition Approved, But Advisors Scale Back Model Development

This article is from The Cancer Letter archive.

Vol. 17 No. 11 | March 15, 1991

Download PDF Visit The Full Archive

Related Articles

FDA Approves Afinitor For pNET; No Word On Sutent For Same Use

May 6, 2011

Southern Gets Two More Contracts Totaling 44.5 Million From NCI

June 14, 1974

Age Doesn’t Affect Survival After Bone Marrow Transplant

December 26, 2008

CMS Draft Coverage Decision Nixes Virtual Colonoscopy

February 13, 2009

FDA Approves Xeloda For Colon Cancer; Phase III Data Not Reviewed By ODAC.

May 4, 2001

ACS Updates Guidelines On Colorectal Screening.

February 2, 2001